Holen Sie sich die Stockscreener-App
2.51
1.95%
-0.05
Handel nachbörslich:
2.51
Schlusskurs vom Vortag:
$2.56
Offen:
$2.52
24-Stunden-Volumen:
62,567
Relative Volume:
1.18
Marktkapitalisierung:
$76.52M
Einnahmen:
$4.01M
Nettoeinkommen (Verlust:
$-38.53M
KGV:
-1.9921
EPS:
-1.26
Netto-Cashflow:
$-32.27M
1W Leistung:
-4.92%
1M Leistung:
-8.73%
6M Leistung:
-19.55%
1J Leistung:
-67.40%
1-Tages-Spanne:
$2.35
$2.56
1-Wochen-Bereich:
$2.35
$2.73
52-Wochen-Spanne:
$2.35
$8.32
Xbiotech Inc Stock (XBIT) Company Profile
Firmenname
Xbiotech Inc
Sektor
Branche
Telefon
512-386-2900
Adresse
5217 WINNEBAGO LANE, AUSTIN, TX
Vergleichen Sie XBIT mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBIT
Xbiotech Inc
|
2.51 | 78.05M | 4.01M | -38.53M | -32.27M | -1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
412.22 | 104.45B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
469.36 | 60.95B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
572.60 | 59.11B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
812.95 | 49.23B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
320.94 | 35.92B | 4.56B | -176.77M | 225.30M | -1.7177 |
Xbiotech Inc Stock (XBIT) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2019-06-14 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-04-21 | Herabstufung | Noble Financial | Buy → Hold |
| 2016-06-28 | Bestätigt | Noble Financial | Buy |
Xbiotech Inc Aktie (XBIT) Neueste Nachrichten
Intraday pattern recognizer results for XBiotech Inc.Global Markets & Daily Technical Forecast Reports - newser.com
Using data models to predict XBiotech Inc. stock movementTrade Risk Assessment & Daily Volume Surge Signals - newser.com
Can swing trading help recover from XBiotech Inc. lossesRate Hike & Fast Momentum Stock Entry Tips - newser.com
Will earnings trigger a reversal in XBiotech Inc.Take Profit & Risk Adjusted Buy/Sell Alerts - newser.com
What risks investors should watch in XBiotech Inc. stock2025 Big Picture & Community Trade Idea Sharing Platform - newser.com
Can volume confirm reversal in XBiotech Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com
Statistical indicators supporting XBiotech Inc.’s strength2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Tick level data insight on XBiotech Inc. volatilityPortfolio Update Report & Low Risk Investment Opportunities - newser.com
XBiotech (NASDAQ:XBIT) Share Price Crosses Below 50-Day Moving AverageShould You Sell? - MarketBeat
Power REIT (PW): What Technical Indicators Show - fostersleader.com
How XBiotech Inc. stock valuations compare to rivalsQuarterly Earnings Report & Weekly Watchlist for Hot Stocks - newser.com
Price action breakdown for XBiotech Inc.Exit Point & High Accuracy Buy Signal Tips - newser.com
Weiss Ratings Reiterates "Sell (E+)" Rating for XBiotech (NASDAQ:XBIT) - MarketBeat
Can VJTF Eduservices Limited Outperform the Market in a Slowing EconomyPortfolio Diversification Tips & Affordable Market Growth - earlytimes.in
How XBiotech Inc. (4XB) stock valuation compares with sectorDay Trade & Expert Approved Trade Ideas - newser.com
Using RSI to spot recovery in XBiotech Inc.2025 Retail Activity & Real-Time Stock Entry Alerts - newser.com
Will XBiotech Inc. stock rally after Fed decisionsJuly 2025 Short Interest & Low Risk High Win Rate Picks - newser.com
Is Bluerock Homes Trust Inc a good long term investmentGrowth vs. Value Investing & Free Phenomenal Trading Returns - earlytimes.in
XBiotech Signs New Executive Agreement with CEO - TipRanks
How sentiment analysis helps forecast XBiotech Inc.Weekly Trade Analysis & Safe Entry Point Identification - newser.com
Will XBiotech Inc. benefit from macro trendsLong Setup & Technical Entry and Exit Alerts - newser.com
Goldman Sachs Group Inc. Has $153,000 Holdings in XBiotech Inc. $XBIT - Defense World
Why XBiotech Inc. (4XB) stock is a strong buy callJuly 2025 Intraday Action & Community Consensus Trade Alerts - newser.com
Finanzdaten der Xbiotech Inc-Aktie (XBIT)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.15%
1.45%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):